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Abstract
Undifferentiated connective tissue diseases (UCTDs) are clinical entities characterised by signs and symptoms
suggestive of a systemic autoimmune disease, which do not fulfil the diagnostic criteria for a defined connective
tissue disease. Lung involvement can complicate the course and management of the disease, often determining a
worse outcome. Respiratory dysfunction as the first clinical manifestation has seldom been reported.
We describe a case of a female patient who developed significant respiratory dysfunction as the principal clinical
sign. Video-assisted thoracoscopy was performed and a histological pattern of nonspecific interstitial pneumonia
(NSIP) was found. A pathological diagnosis suggested careful follow-up with extensive immunological screening
which then detected Raynaud’s phenomenon and positivity of antinuclear antibodies. After a multidisciplinary
discussion (pneumologist, radiologist, pathologist and rheumatologist) a final diagnosis of NSIP associated with
UCTD was made. The diagnosis of UCTD should be considered when NSIP is diagnosed even in cases with evident
first clinical manifestations of severe respiratory dysfunction. A multidisciplinary approach in the field of interstitial
lung disease with NSIP, also including rheumatologic expertise, is fundamental to achieve a prompt and correct
diagnosis.
Background
The term undifferentiated connective tissue disease
(UCTD) is used to define clinical entities characterised
by features suggestive of CTD which do not meet the
classification criteria of the American College of Rheu-
matology for a specific single disease, such as systemic
lupus erythematosus, systemic sclerosis, polymyositis/
dermatomyositis, and Sjögren’s syndrome [1-9]. UCTD
can evolve in these patients over time.
As only a few reports have described lung involvement
during UCTD the natural history still remains unknown
and unpredictable. Interstitial lung disease (ILD) with a
histological pattern of non specific interstitial pneumo-
nia (NSIP) has recently been reported to be the most
frequent lung manifestation [10-13], usually responsible
for progression and adverse outcome of the disease.
Lung involvement as the first clinical manifestation of
UCTD is rarely reported. We discuss the case and
review the associated literature of UCTD.
Case Presentation
Clinical summary
A 50-year-old non-smoking female textile worker after a
flu-like episode started to suffer from dry cough and pro-
gressive dyspnoea. Chest radiography showed parenchy-
mal pulmonary opacity in the lower posterior segment of
the right haemithorax and bilateral interstitial thickening
of the lower pulmonary segment. The patient was there-
fore treated with antibiotics and steroids but the clinical
and radiological manifestations did not improve.
Computed tomography (CT) scan of the lungs three
months later revealed a ground glass pattern in the apical
segment of the upper and lower lobes. Lymphadenopathy
in the paratracheal space was also observed (Figure 1).
The laboratory results showed an increased level of
inflammatory parameters (erythrocyte sedimentation
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492 mg/dl), without any other positive tests (e.g. rheuma-
toid factor). The pulmonary function test showed a
restrictive pattern (vital capacity: 1.59 L, 50% predicted;
total lung capacity: 3.94 L, 75% predicted) with a reduc-
tion in the single breath diffusion capacity of carbon
monoxide (TLCO/VA 0.84 mmol/min/kPa/l, 52% pre-
dicted). Arterial oxygen tension at rest was normal (pH:
7.44; pO2: 92.4 mmHg; pCO2: 38.8 mmHg). A six-minute
walking test revealed oxygen desaturation (87%) with
severe dyspnoea (BORG scale 5/10). Bronchoscopy with
combined bronchoalveolar lavage and transbronchial
biopsies were performed, but they provided no significant
additional information.
Open lung biopsy was performed and based on a histo-
logical diagnosis of non specific interstitial pneumonia
(NSIP) an accurate immunological follow-up was required.
T h ea s s a yo fal a r g e rp a n e lo fa u t o a n t i b o d i e ss h o w e d
only positivity of antinuclear antibodies (ANA), at titer
1/160. The other investigated antibodies (such as anti-
ENA, anti-DNAds, anti-centromere, anti-cyclic citrulli-
nated peptide and anti-tRNA synthetases) were all
negative. Finally, a nailfold capillaroscopy (NFC) was
recommended and showed the presence of minor capil-
lary changes characteristic of a nonspecific pattern
(Figure 2). Clear-cut signs of Raynaud’sp h e n o m e n o n
(RP) were then reported during rheumatologic follow-
up. After a multidisciplinary discussion (pneumologist,
radiologist, pathologist and rheumatologist) a final diag-
nosis of NSIP associated with UCTD was made.
Therefore, the patient was discharged and started a
treatment regimen of oral cyclophosphamide (100 mg/
die) and prednisone (25 mg/die) for 12 months. The
combination was then stopped and the patient was fol-
lowed only with low dose of corticosteroids.
Up to now, over a follow-up period of three years, the
clinical picture and the pulmonary function test remain
stable and no definitive CTD has developed.
Pathological findings
Low-magnification microscopy showed an uniform
alveolar septa thickening by cellular infiltrate and fibro-
sis. At higher magnification, the alveolar septal intersti-
tium was expanded by mild inflammation and collagen
deposition with minimal honeycomb changes. No fibro-
blastic foci and active fibrosis were seen and patchy
lymphoid aggregates were occasionally visible. The inter-
stitial chronic inflammation consisted of lymphocytes and
some plasma cells. Increased macrophagic infiltration was
seen in some alveolar spaces. The appearance was consis-
tent with the fibrosing variant of NSIP (Figure 3). Organis-
ing pleuritis with mesothelial hyperplasia was present.
Medial vessel thickening was particularly seen in remo-
delled lung areas.
Conclusions
Up to 25% of patients who show clinical and laboratory
features of systemic autoimmune diseases do not fulfil
the classification criteria of ACR for a specific CTD and
they are considered to have a distinct clinical entity,
called UCTD [1,4,7,8]. The definition is still under
debate, although it is becoming more definite. In 1999
and 2006 Mosca et al. reviewed the literature and
Figure 1 Computed tomography scan of the lung.A :A x i a lC T
scan shows right paratracheal linfoadenopathy B: Axial HRCT scan
shows septal interlobular thickening with ground glass opacities at
the lower lobes.
Figure 2 Capillaroscopy images. Abnormal capillary shape with
winding and acrocyanotic capillaries.
Figure 3 Histological pattern in lung biopsy. Panoramic view
showed interstitial inflammatory cell infiltration sometimes
aggregated in follicular pattern (arrows). Vessel remodelling
(arrowhead) is also well seen (original magnification, haematoxylin-
eosin stain: 40x).
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UCTD include the following: at least one clinical mani-
festation of CTD, positive ANA results, and a disease
duration of at least three years [4,8].
It may be difficult to distinguish these conditions from
early phases of defined diseases such as systemic lupus
erythematosus, systemic sclerosis and others. The nat-
ural history of these rare entities is variable: a high per-
centage of patients with UCTD maintain an
undifferentiated clinical course and do not evolve to a
distinct CTD, whereas some patients can evolve over
time [4,7,8,11].
Laboratory test screening is essential to identify mar-
kers that may suggest a systemic, autoimmune disease,
or specific organ involvement. In fact, about 90% of the
patients with UCTD show positive ANA [1,5]. Capillaro-
scopy is useful to detect abnormalities in capillary shape
and blood flow, which suggest features of Raynaud’s
phenomenon.
The onset of UCTD is similar to most CTDs, peaking
in the middle years of life. There are no specific signs or
symptoms of UCTDs because these entities present
manifestations common to other CTDs. The main clini-
cal features at onset of UCTD are arthritis and arthral-
gia, Raynaud’s phenomenon, pleuritis and pericarditis,
xerostomia and xerophtalmia, leukopenia, esophageal
involvement, fever and myositis [1,9,14]. Major organ
involvement is unusual and the lung has been reported
as a late complication, often determining a worse out-
come [15].
Recently an ATS working group described idiopathic
NSIP as a distinct entity that occurs mostly in middle-
aged women who never smoked and who often have
positive serologic tests (antinuclear antibodies or rheu-
matoid factor) [16].
The typical histological findings of NSIP detected in
our patient who also presented the clinical phenotype
(middle-aged, non-smoking woman) suggested an addi-
tional careful investigation for an accurate rheumatolo-
gic evaluation and follow-up.
Kinder et al. recently showed that the majority of
patients (88%) who met the UCTD criteria had distinct
radiological and pathological features of NSIP, thus
emphasizing that this pattern is peculiar of the disease
[10]. The same group more recently highlighted the
concept that patients with UCTD and lung involvement
have improved pulmonary function during the follow-
up, as in our case [11] compared to other unfavourable
interstitial diseases as idiopathic pulmonary fibrosis.
Lung involvement usually appears as a complication in
established UCTD. There is only a recent study which has
demonstrated that NSIP may be the first clinical manifes-
tation of the disease [13], as in our case. The prospective
s t u d yb yR o m a g n o l iet al. demonstrated that more than
50% of patients diagnosed with NSIP showed an autoim-
mune disease, as UCTD, in their follow-up. In particular,
UCTD was detected in 22% of NSIP patients [13].
In conclusion, we have described a case of a patient
with UCTD whose first clinical manifestation was lung
involvement. UCTD should be considered when NSIP is
diagnosed even in cases with evident first clinical mani-
festations of severe respiratory dysfunction.
A multidisciplinary approach with the intervention of
pneumologists, radiologists, pathologists and rheumatol-
ogists is recommended to achieve a correct diagnosis.
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